PTS Indication PTS302 Severe Malignant Airway Obstruction PTS100 Hepatocellular Carcinoma PTS-02 Adenoid cystic carcinoma PTS500 Malignant pleural effusion Pre-clinical phase Clinical phase I Clinical phase II Clinical phase III NDA Submission Market Approval New product PTS037 New ingredient development PTS040 New ingredient development Pre-clinical phase Clinical phase I Clinical phase II Clinical phase III NDA Submission Market Approval
